Kristi Glanzer
Nurse Practitioner · Huron, SDNPI 1245232008
Payments from drug & device makers
Across 452 payments — averaging $13.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$870
- Novo Nordisk$703
- Pfizer$579
- Amgen$470
- Grifols USA, LLC$389
- AbbVie$353
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,10998%
- Education$1072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 72 | $870 |
| Novo Nordisk | 60 | $703 |
| Pfizer | 52 | $579 |
| Amgen | 41 | $470 |
| Grifols USA, LLC | 20 | $389 |
| AbbVie | 23 | $353 |
| Johnson & Johnson | 28 | $333 |
| AstraZeneca | 11 | $309 |
| Boehringer Ingelheim | 22 | $309 |
| Astellas Pharma US Inc | 16 | $291 |
| Novartis | 13 | $219 |
| Amarin Pharma, Inc. | 13 | $165 |
| Bayer | 7 | $158 |
| GSK | 11 | $156 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $128 |
| E.r. Squibb & Sons, L.L.C. | 7 | $101 |
| Merck | 7 | $91 |
| Supernus Pharmaceuticals, Inc. | 4 | $88 |
| Exact Sciences | 5 | $75 |
| Biohaven Pharmaceuticals, Inc. | 6 | $75 |
| Phathom Pharmaceuticals, Inc. | 6 | $60 |
| Mylan Specialty L.p. | 3 | $50 |
| Sanofi-aventis U.S. LLC | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Abbott | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Pelvital USA, Inc. | 1 | $19 |
| Philips North America LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,215 in reported general payments places this provider in the 95th percentile of 504 nurse practitioner providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 163 | $173,328 |
| OzempicSemaglutide | 103 | $109,535 |
| EliquisApixaban | 77 | $74,587 |
| JardianceEmpagliflozin | 70 | $56,441 |
| TrulicityDulaglutide | 55 | $54,285 |
| FarxigaDapagliflozin Propanediol | 64 | $52,134 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $37,708 |
| XareltoRivaroxaban | 41 | $33,614 |
| Nurtec OdtRimegepant Sulfate | 16 | $22,094 |
| OxycontinOxycodone Hcl | 13 | $18,740 |
| LinzessLinaclotide | 32 | $17,190 |
| EntrestoSacubitril/Valsartan | 17 | $15,372 |
| MyrbetriqMirabegron | 20 | $14,798 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $11,216 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 22 | $6,676 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $870 | $227,612218 claims |
| Novo NordiskOzempic | $703 | $109,535103 claims |
| PfizerEliquis, Nurtec Odt | $579 | $96,68193 claims |
| Boehringer IngelheimJardiance | $309 | $56,44170 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $156 | $54,99775 claims |
| AstraZenecaFarxiga | $309 | $52,13464 claims |
| Johnson & JohnsonXarelto | $333 | $33,61441 claims |
| AbbVieLinzess | $353 | $17,19032 claims |
| NovartisEntresto | $219 | $15,37217 claims |
| Astellas Pharma US IncMyrbetriq | $291 | $14,79820 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 504 nurse practitioner providers in South Dakota.
Other nurse practitioner in Huron
- Jamie BuschSioux Falls$60K
- Jessica SlabaSioux Falls$41K
- Christopher NelsonSioux Falls$35K
- Katherine EricsonSioux Falls$13K
- Rosa EytonAberdeen$7K
- Roger DeraadRapid City$6K
- Gabrielle PriceSioux Falls$5K
- Jacqueline KelleySioux Falls$5K
- Jessica YoshinoSioux Falls$5K
- Kristen NelsonRapid City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.